Baxter reportedly close to selling cardiac device business to Thoratec
This article was originally published in Clinica
Executive Summary
Baxter is reported to be on the verge of selling its Novacor cardiac device business to Thoratec Laboratories. An isolated news report from the Chicago Tribune claimed that the Deerfield, Illinois-based device manufacturer was about to divest its portable left-ventricular assist device to Pleasanton, California-based Thoratec after disillusionment over the earning potential of the device.